Genetics and Immunology Reproductive Immunology

The costimulatory signal upregulation is associated with Th1 bias at the maternal-fetal interface in human miscarriage

Jin LP, Fan DX, Zhang T, Guo PF, Li DJ

Published October 2011 American journal of reproductive immunology (New York, N.Y. : 1989), 66(4), 270-8
DOI 10.1111/j.1600-0897.2011.00997.x PMID 21481059

Abstract

Problem

To evaluate whether the association of the costimulatory signal regulation with T helper 1/T helper 2 (Th1/Th2) bias at maternal-fetal interface in human pregnancy loss.

Methods of Study Selection

The expression of CD80 and CD86 in decidual tissues and CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in the decidual T cells was compared between normal early pregnancy and miscarriage by qPCR and Western blot. The cytokine production in decidual T cells was performed by flow cytometry. The correlation of costimulatory molecule expression with Th1/Th2 cytokines was analyzed.

Results

The CD80 mRNA and protein expression showed no significant difference between normal pregnancy and miscarriage. An increase in the expression of CD28 and CD86 was accompanied by a decrease in the expression of CTLA-4 in miscarriage in comparison with the early pregnancy. The higher expression of interleukin (IL)-2 and interferon-γ (IFN-γ), and lower expression of IL-4 and IL-10 in the decidual T cells were present in miscarriage. A correlation analysis showed a significant positive correlation of CD86 and CD28 expression with the Th1 cytokine production (IL-2 and IFN-γ), a significant negative correlation of CTLA-4 expression with the Th1 cytokine production.

Conclusion

The upregualtion of costimulatory signals on T cells might form an abnormal immune microenvironment, a shift to Th1 responses, at maternal-fetal interface, which leads to human miscarriage.

Read the guide

  • Miscarriage and Recurrent Pregnancy Loss: The Workup Most Women Never Get

    Miscarriage affects approximately 15% of clinically confirmed pregnancies. Recurrent pregnancy loss (RPL), defined as two or more clinical losses, affects 2 to 5% of couples. Most causes are diagnosable and treatable. This guide covers what the standard workup misses, what RRM-trained clinicians evaluate, and what outcomes look like after cause-based treatment.

    22 min read

Topics

Related research

Genetics and Immunology › Reproductive Immunology › Implantation Immunology · Pregnancy › Pregnancy Complications › Intrauterine Infection · Infertility › Recurrent Pregnancy Loss › Immune and Thrombophilia Factors
Li-Ping Jin, Deng-Xuan Fan, Tai Zhang, Pei-Fen Guo, Da-Jin Li
L Jin, D Fan, T Zhang, P Guo, D Li
PMID 21481059 21481059 DOI 10.1111/j.1600-0897.2011.00997.x 10.1111/j.1600-0897.2011.00997.x Jin et al. 2011, Jin 2011